The cost of asthma control
Asthma care has advanced significantly. This is attributed to a better understanding of clinical disease phenotypes and overlapping molecular endotypes amenable to therapy. Despite improvements inasthma care, rates of asthma control remain suboptimal. Adult asthma rates in Asia are lower than that in...
| Päätekijä: | |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Journal Article |
| Kieli: | English |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://hdl.handle.net/10356/80789 http://hdl.handle.net/10220/42255 |
| _version_ | 1826117862803111936 |
|---|---|
| author | Chotirmall, Sanjay Haresh |
| author2 | Lee Kong Chian School of Medicine (LKCMedicine) |
| author_facet | Lee Kong Chian School of Medicine (LKCMedicine) Chotirmall, Sanjay Haresh |
| author_sort | Chotirmall, Sanjay Haresh |
| collection | NTU |
| description | Asthma care has advanced significantly. This is attributed to a better understanding of clinical disease phenotypes and overlapping molecular endotypes amenable to therapy. Despite improvements inasthma care, rates of asthma control remain suboptimal. Adult asthma rates in Asia are lower than that in Europe; however, emerging trends and ageing populations in Asia mean that disease burden is likely to rise. Early work published over a decade ago suggests that levels of asthma control within the Asia-Pacific were short of that expected from international guidelines. Recent data derived from the Asia-Pacific Asthma Insights and Management (AIM) survey reveal some potential explanations: more than half of all participants reported completely or well-controlled asthma but concurrently two-thirds admitted to an exacerbation averaging 5 days and missed work or school time. This discordance in understanding asthma control among Asian patients is further evidenced by data from the REcognise Asthma and LInk to Symptoms and Experience (REALISE) Study that assessed perception of asthma control and attitudes towards treatment in 2467 patients in a real-life setting. Patients were found to consistently overestimate their levels of asthma control contrary to symptoms and critically found to perceive the management of exacerbations as a control measure. |
| first_indexed | 2024-10-01T04:34:19Z |
| format | Journal Article |
| id | ntu-10356/80789 |
| institution | Nanyang Technological University |
| language | English |
| last_indexed | 2024-10-01T04:34:19Z |
| publishDate | 2017 |
| record_format | dspace |
| spelling | ntu-10356/807892020-11-01T05:18:24Z The cost of asthma control Chotirmall, Sanjay Haresh Lee Kong Chian School of Medicine (LKCMedicine) Cost Asthma Asthma care has advanced significantly. This is attributed to a better understanding of clinical disease phenotypes and overlapping molecular endotypes amenable to therapy. Despite improvements inasthma care, rates of asthma control remain suboptimal. Adult asthma rates in Asia are lower than that in Europe; however, emerging trends and ageing populations in Asia mean that disease burden is likely to rise. Early work published over a decade ago suggests that levels of asthma control within the Asia-Pacific were short of that expected from international guidelines. Recent data derived from the Asia-Pacific Asthma Insights and Management (AIM) survey reveal some potential explanations: more than half of all participants reported completely or well-controlled asthma but concurrently two-thirds admitted to an exacerbation averaging 5 days and missed work or school time. This discordance in understanding asthma control among Asian patients is further evidenced by data from the REcognise Asthma and LInk to Symptoms and Experience (REALISE) Study that assessed perception of asthma control and attitudes towards treatment in 2467 patients in a real-life setting. Patients were found to consistently overestimate their levels of asthma control contrary to symptoms and critically found to perceive the management of exacerbations as a control measure. Accepted version 2017-04-13T05:35:16Z 2019-12-06T13:58:58Z 2017-04-13T05:35:16Z 2019-12-06T13:58:58Z 2017 Journal Article Chotirmall, S. H. (2017). The cost of asthma control. Respirology, 22(3), 414-415. 1323-7799 https://hdl.handle.net/10356/80789 http://hdl.handle.net/10220/42255 10.1111/resp.12991 en Respirology © 2017 Asian Pacific Society of Respirology. This is the author created version of a work that has been peer reviewed and accepted for publication by Respirology, Asian Pacific Society of Respirology. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.1111/resp.12991]. 8 p. application/pdf |
| spellingShingle | Cost Asthma Chotirmall, Sanjay Haresh The cost of asthma control |
| title | The cost of asthma control |
| title_full | The cost of asthma control |
| title_fullStr | The cost of asthma control |
| title_full_unstemmed | The cost of asthma control |
| title_short | The cost of asthma control |
| title_sort | cost of asthma control |
| topic | Cost Asthma |
| url | https://hdl.handle.net/10356/80789 http://hdl.handle.net/10220/42255 |
| work_keys_str_mv | AT chotirmallsanjayharesh thecostofasthmacontrol AT chotirmallsanjayharesh costofasthmacontrol |